Disruption of the Mouse Cyclooxygenase 1 Gene

[1]  J. Johnston,et al.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.

[2]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[3]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[4]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[5]  R. Tennant,et al.  Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. , 1995, Environmental health perspectives.

[6]  P. Pasricha,et al.  The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. , 1995, Gastroenterology.

[7]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[8]  K. Namboodiri,et al.  Breast cancer and NSAID use: heterogeneity of effect in a case-control study. , 1995, Preventive medicine.

[9]  F. Marks,et al.  Differential expression of prostaglandin h synthase isozymes during multistage carcinogenesis in mouse epidermis , 1995, Molecular carcinogenesis.

[10]  K. Seibert,et al.  Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Kelly.  Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. , 1994, Endocrine reviews.

[12]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[13]  K. Seibert,et al.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Vane,et al.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Vane.  Towards a better aspirin , 1994, Nature.

[16]  D. Dewitt,et al.  PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. , 1993, The American journal of medicine.

[17]  V. Steele,et al.  Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam. , 1993, Carcinogenesis.

[18]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[19]  L. Marnett.  Aspirin and the potential role of prostaglandins in colon cancer. , 1992, Cancer research.

[20]  J. Richards,et al.  Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro. , 1992, The Journal of biological chemistry.

[21]  B. Varnum,et al.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.

[22]  G. FitzGerald,et al.  Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[24]  S. Gad,et al.  Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). , 1986, Toxicology and applied pharmacology.

[25]  E. Opas,et al.  Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. , 1985, The Journal of investigative dermatology.

[26]  A. Robert.  An intestinal disease produced experimentally by a prostaglandin deficiency. , 1975, Gastroenterology.

[27]  G. Thorburn.  The placenta, prostaglandins and parturition: a review. , 1991, Reproduction, fertility, and development.

[28]  V. Steele,et al.  Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1 , 2022 .